Wantai Biotech announced that revenue for the first half of 2026 was 1,048 billion yuan, an increase of 24.29% over the previous year. Net profit loss attributable to shareholders of listed companies was 128 million yuan, compared with a loss of 144 million yuan for the same period last year. Loss of $169 million after deducting non-net profit.

Wantai Biotech announced that revenue for the first half of 2026 was 1,048 billion yuan, an increase of 24.29% over the previous year. Net profit loss attributable to shareholders of listed companies was 128 million yuan, compared with a loss of 144 million yuan for the same period last year. Loss of $169 million after deducting non-net profit.